1. Background
2. Objectives
3. Methods
3.1. Bacterial Isolation
3.2. Antibiotic Susceptibility Test
3.3. PCR Amplification
3.4. Multilocus Sequence Typing Analysis
3.5. Conjugation Experiments
3.6. Genome Sequencing and Assembly
3.7. Gene prediction, Annotation, and Protein Classification
4. Results
4.1. Antimicrobial Susceptibility Testing, Conjugation, and Multilocus Sequence Typing
| Resistance Genes and % Identity a/ Antimicrobial Category/Antimicrobial Agent | Antimicrobial Susceptibility Test | ||
|---|---|---|---|
| MIC b (mg/L) | MIC c (mg/L) | K-B | |
| TEM-1 (100), SHV-66 (99.65), TEM-95 (99.25), KPC-2 (100), NDM-1 (100), ATC-17 (99.74) | |||
| β-lactams | |||
| Ampicillin | ≥ 32 | - | - |
| Piperacillin | ≥ 128 | - | - |
| Cefazolin | ≥ 64 | - | - |
| Ceftriaxone | ≥ 64 | - | - |
| Cefotaxime | - | - | 6 |
| Ceftazidime | ≥ 64 | - | - |
| Cefepime | ≥ 64 | - | - |
| Imipenem | ≥ 16 | > 32 | - |
| Meropenem | 8 | > 32 | - |
| Ertapenem | ≥ 8 | > 32 | - |
| Monobactams | |||
| Aztreonam | ≥ 64 | - | - |
| Penicillins/β-lactamase inhibitors | |||
| Amoxicillin/Clavulanate | ≥ 32/16 | - | - |
| Ampicillin/Sulbactam | - | - | 6 |
| Piperacillin/Tazobactam | - | - | 6 |
| Cephalosporins/β-lactamase inhibitors | |||
| Cefoperazone/Sulbactam | - | - | 6 |
| APH (3’)-Ia (98.42), aadA (99.62), APH (6’)-Id (99) | |||
| Aminoglycosides | |||
| Gentamicin | ≤ 1 | - | - |
| Amikacin | ≥ 64 | - | - |
| Fluoroquinolones | |||
| Ciprofloxacin | ≥ 4 | - | - |
| Levofloxacin | ≥ 8 | - | - |
| Sul2 (100) | |||
| Sulfonamides | |||
| Trimethoprim/Sulfamethoxazole | ≥ 320 | - | - |
| FosA2 (95.04) | |||
| Phosphonic acids | |||
| Fosfomycin | - | - | 18 (ND) |
| Nitrofurans | |||
| Nitrofurantoin | 32 | - | - |
| tetA, tetR | |||
| Tetracyclines | |||
| Tetracycline | ≥ 16 | - | - |
Abbreviations: ND, no definition; MIC, minimal inhibitory concentration.
a The table showed a nucleotide identity above 90% of resistance genes.
b MIC was performed by VITEK 2 system.
c MIC was performed by E-test.
4.2. Genomic Features and PCR Analysis
4.3. Genetic Characteristics of Plasmids
| Studied Plasmids | Compared Plasmids | Isolate | Country | Query Cover (%) | Nucleotide Identity (%) | GenBank No. |
|---|---|---|---|---|---|---|
| pECL189-1 | pCRE3-KPC | Citrobacter braakii | China | 53 | 99 | MH9193878.1 |
| pECL189-2 | p34399-121.660 | Enterobacter hormaechei | USA | 95 | 99.80 | CP010386.1 |
| pECL189-2 | pXM-70A | E. hormaechei | China | 88 | 98.94 | CP046272.1 |
| pECL189-2 | p1-020038 | E. hormaechei | China | 88 | 98.73 | CP031722.1 |
| pECL189-2 | pG6809-1 | E.r cloacae | USA | 86 | 98.81 | KT345945.1 |
| pECL189-3 | unnamed5 | E. hormaechei | USA | 100 | 100 | CP030350.1 |
| pECL189-3 | p34399-106.698 | E. hormaechei | USA | 100 | 100 | CP010385.1 |
| pECL189-3 | unnamed1 | E. cloacae | Unpublished | 100 | 99.98 | CP020526.1 |
| pECL189-3 | pQnrS1-1502262 | E. hormaechei | USA | 100 | 100 | CP031572.1 |
| pECL189-4 | pCRE1.4 | Escherichia coli | Thailand | 99 | 100 | CP034398.1 |
| pECL189-4 | pNH25.5 | Klebsiella pneumoniae | Thailand | 94 | 100 | CP024879.1 |
| pECL189-4 | pNDM-ECS01 | E. coli | Thailand | 99 | 100 | KJ413946.1 |
| pECL189-4 | pTR3 | K. pneumoniae | Taiwan | 99 | 100 | JQ349086.2 |
| pECL189-4 | pCRE10.4 | E. coli | Thailand | 99 | 100 | CP034403.1 |
| pECL189-4 | pEcloNH77 | E. cloacae | Thailand | 99 | 99.98 | CP040826.1 |

